These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37543722)

  • 1. Optimizing medication adherence with home-monitoring - A feasibility study using capillary microsampling and mHealth in solid organ-transplanted adolescents.
    Kindem IA; Åsberg A; Midtvedt K; Bjerre A
    Pediatr Transplant; 2023 Nov; 27(7):e14590. PubMed ID: 37543722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus Measured in Capillary Volumetric Microsamples in Pediatric Patients-A Cross-Validation Study.
    Kindem IA; Bjerre A; Åsberg A; Midtvedt K; Bergan S; Vethe NT
    Ther Drug Monit; 2021 Jun; 43(3):371-375. PubMed ID: 33596033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients.
    Vethe NT; Gustavsen MT; Midtvedt K; Lauritsen ME; Andersen AM; Åsberg A; Bergan S
    Ther Drug Monit; 2019 Oct; 41(5):607-614. PubMed ID: 31584926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling.
    Gustavsen MT; Midtvedt K; Vethe NT; Robertsen I; Bergan S; Åsberg A
    Ther Drug Monit; 2020 Jun; 42(3):407-414. PubMed ID: 31479042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.
    Mellon L; Doyle F; Hickey A; Ward KD; de Freitas DG; McCormick PA; O'Connell O; Conlon P
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012854. PubMed ID: 36094829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Once- Versus Twice-Daily Tacrolimus Dosing on Medication Adherence in Stable Renal Transplant Recipients: A Canadian Single-Center Randomized Controlled Trial.
    Paterson TSE; Demian M; Shapiro RJ; Loken Thornton W
    Can J Kidney Health Dis; 2019; 6():2054358119867993. PubMed ID: 31452902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in medication adherence by sex and organ type among adolescent and young adult solid organ transplant recipients.
    Vaisbourd Y; Dahhou M; Zhang X; Sapir-Pichhadze R; Cardinal H; Johnston O; Blydt-Hansen TD; Tibbles LA; Hamiwka L; Urschel S; Birk P; Bissonnette J; Matsuda-Abedini M; BScPhm JH; Schiff J; Phan V; De Geest S; Allen U; Avitzur Y; Mital S; Foster BJ
    Pediatr Transplant; 2023 Mar; 27(2):e14446. PubMed ID: 36478059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial.
    Han A; Min SI; Ahn S; Min SK; Hong HJ; Han N; Kim YS; Ahn C; Ha J
    PLoS One; 2019; 14(11):e0224595. PubMed ID: 31689320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial.
    McGillicuddy JW; Chandler JL; Sox LR; Taber DJ
    Ann Pharmacother; 2020 Dec; 54(12):1185-1193. PubMed ID: 32506922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Medication Adherence with the Use of Extended-Release Tacrolimus in Liver Transplant Recipients: A Pilot Randomized Controlled Trial.
    Verma M; Zaki R; Sadeh J; Knorr JP; Gallagher M; Parsikia A; Navarro V
    J Transplant; 2023; 2023():7915781. PubMed ID: 36642992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland.
    Bonani M; Balaphas A; Bedino G; Bühler L; Dutkowski P; Fausch K; Gluderer S; Graf N; Hirt-Minkowski P; Müllhaupt B; Schönholzer C; Schulz MM; Venzin R; Wüthrich RP
    Swiss Med Wkly; 2021 Feb; 151():w20453. PubMed ID: 33638353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric Microsampling of Capillary Blood Spot vs Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus and Cyclosporin A: Accuracy and Patient Satisfaction.
    Mbughuni MM; Stevens MA; Langman LJ; Kudva YC; Sanchez W; Dean PG; Jannetto PJ
    J Appl Lab Med; 2020 May; 5(3):516-530. PubMed ID: 32445361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients.
    Maurer MM; Ibach M; Plewe J; Winter A; Ritschl P; Globke B; Öllinger R; Lurje G; Schöning W; Pratschke J; Eurich D
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily tacrolimus extended-release formulation: 1 year after conversion in stable pediatric kidney transplant recipients.
    Pape L; Heidotting N; Ahlenstiel T
    Int J Nephrol; 2011; 2011():126251. PubMed ID: 21647310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning - A randomized controlled single center feasibility study.
    Wagner-Skacel J; Fink N; Kahn J; Dalkner N; Jauk E; Bengesser S; Mairinger M; Schüssler G; Pieh C; Stadlbauer V; Kirsch AH; Zitta S; Rosenkranz AR; Fickert P; Schemmer P
    Front Psychol; 2023; 14():1150548. PubMed ID: 36968754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.
    Doesch AO; Mueller S; Akyol C; Erbel C; Frankenstein L; Ruhparwar A; Ehlermann P; Dengler TJ; Katus HA
    Drug Des Devel Ther; 2013; 7():1253-8. PubMed ID: 24174870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived barriers to medication adherence remain stable following solid organ transplantation.
    Danziger-Isakov L; Frazier TW; Worley S; Williams N; Shellmer D; Dharnidharka VR; Gupta NA; Ikle D; Shemesh E; Sweet SC;
    Pediatr Transplant; 2019 May; 23(3):e13361. PubMed ID: 31332928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Randomized Trial Investigating the Influence of Pharmaceutical Care on the Intra-Individual Variability of Tacrolimus Concentrations Early After Kidney Transplant.
    Bessa AB; Felipe CR; Hannun P; Sayuri P; Felix MJ; Ruppel P; Ferreira AN; Cristelli MP; Viana L; Mansur JB; Basso G; Aguiar WF; Tedesco-Silva H; Medina-Pestana J
    Ther Drug Monit; 2016 Aug; 38(4):447-55. PubMed ID: 27414973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of converting adult kidney transplant recipients with high tacrolimus variability from twice daily immediate release tacrolimus to once daily LCP-Tacrolimus.
    Taber DJ; Bartlett F; Patel N; Sprague T; Patel S; Newman J; Andrade E; Rao N; Salas MAP; Casey M; Dubay D; Rohan V
    Clin Transplant; 2023 May; 37(5):e14941. PubMed ID: 36809653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Analysis of Tacrolimus Intrapatient Variability as a Measure of Medication Adherence.
    Herblum J; Dacouris N; Huang M; Zaltzman J; Prasad GVR; Nash M; Chen L
    Can J Kidney Health Dis; 2021; 8():20543581211021742. PubMed ID: 34188946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.